Prelude Therapeutics Incorporated
NASDAQ:PRLD
1.19 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 25.291 | 30.605 | 31.828 | 218.309 | 18.879 | 15.595 |
| Short Term Investments
| 207.644 | 171.123 | 259.405 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 232.935 | 201.728 | 291.233 | 218.309 | 18.879 | 15.595 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.654 | 2.652 | 3.882 | 2.5 | 1.345 | 0 |
| Total Current Assets
| 235.589 | 204.38 | 295.115 | 220.809 | 20.224 | 15.595 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 37.737 | 6.7 | 5.636 | 2.48 | 1.647 | 0.811 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 4.044 | 4.044 | 4.044 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.295 | 5.376 | 0.303 | 0.301 | 0 | 0 |
| Total Non-Current Assets
| 42.076 | 16.12 | 9.983 | 2.781 | 1.647 | 0.811 |
| Total Assets
| 277.665 | 220.5 | 305.098 | 223.59 | 21.871 | 16.406 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.58 | 6.777 | 7.84 | 3.92 | 1.974 | 1.362 |
| Short Term Debt
| 1.481 | 1.832 | 1.74 | 0 | 0.258 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 14.823 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.945 | 13.093 | 9.621 | 7.455 | 2.603 | 1.085 |
| Total Current Liabilities
| 21.829 | 21.702 | 19.201 | 11.375 | 4.835 | 2.447 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 15.407 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 3.339 | 3.361 | 0 | 0.032 | 66.448 | 36.652 |
| Total Non-Current Liabilities
| 18.746 | 3.361 | 0 | 0.032 | 66.448 | 36.652 |
| Total Liabilities
| 40.575 | 25.063 | 19.201 | 11.407 | 71.283 | 39.099 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 223.59 | 66.443 | 36.595 |
| Common Stock
| 0.005 | 0.005 | 0.005 | 0.004 | 0 | 0 |
| Retained Earnings
| -456.39 | -334.558 | -219.12 | -107.426 | -50.497 | -22.927 |
| Accumulated Other Comprehensive Income/Loss
| 0.223 | -1.692 | -0.711 | -223.59 | 0 | -0.191 |
| Other Total Stockholders Equity
| 693.252 | 531.682 | 505.723 | 319.605 | -65.358 | -36.17 |
| Total Shareholders Equity
| 237.09 | 195.437 | 285.897 | 212.183 | -49.412 | -22.693 |
| Total Equity
| 237.09 | 195.437 | 285.897 | 212.183 | -49.412 | -22.693 |
| Total Liabilities & Shareholders Equity
| 277.665 | 220.5 | 305.098 | 223.59 | 21.871 | 16.406 |